Literature DB >> 10955322

Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study.

H Kato1, M Yamakawa, T Ogino.   

Abstract

OBJECTIVE: To evaluate morphologically and immunohistochemically the role of IgM rheumatoid factor (RF) immune complexes and complement activation in rheumatoid nodule vascular injury, a typical extraarticular manifestation of rheumatoid arthritis.
METHODS: Histological features such as cellular infiltration, endothelial alteration, fibrinoid degeneration, and basement membrane alterations were observed in the small vessels in rheumatoid nodules. An immunohistochemical study was also carried out.
RESULTS: Distinct colocalization of IgM RF and terminal complement complexes (TCC: C5b-9) was observed on the luminal surface in some of the damaged endothelial cells. Immuno-electron microscopy revealed endothelial vesiculation, typical of the in vitro protective mechanism against complement attack, with deposition of not only TCC but also IgM RF. Most TCC positive endothelial cells simultaneously expressed the major complement regulatory factor, CD59.
CONCLUSION: These data suggest that, in rheumatoid nodules, vascular injury mediated by complement activation involves the assembly of IgM RF on the endothelial cell surface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955322

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Authors:  Carolyn Jean Chua-Aguilera; Burkhard Möller; Nikhil Yawalkar
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  [Differential diagnosis of rheumatoid granuloma].

Authors:  M Knöss; M G Krukemeyer; T Gehrke; C Otto; C Meyer-Scholten; M Otto; J Kriegsmann
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

3.  The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Alaa Quisi; Gökhan Alıcı
Journal:  J Clin Lab Anal       Date:  2018-06-26       Impact factor: 2.352

4.  [Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab].

Authors:  M G Braun; P Wagener
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

5.  [Extra-articular manifestations of rheumatoid arthritis].

Authors:  C Baerwald; C Kneitz; M Bach; M Licht
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

6.  Effect of rheumatoid factor on mortality and coronary heart disease.

Authors:  Gunnar Tomasson; Thor Aspelund; Thorbjorn Jonsson; Helgi Valdimarsson; David T Felson; Vilmundur Gudnason
Journal:  Ann Rheum Dis       Date:  2009-07-23       Impact factor: 19.103

7.  Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis.

Authors:  Anne R Kinderlerer; Rivka Steinberg; Michael Johns; Sarah K Harten; Elaine A Lidington; Dorian O Haskard; Patrick H Maxwell; Justin C Mason
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  The relationship between rheumatoid factor levels and coronary artery lesion complexity and severity in patients with stable coronary artery disease.

Authors:  Elnur Alizade; Anıl Avcı; Göksel Açar; Serdar Fidan; Lütfi Öcal; Mustafa Bulut; Muhammed Tellice; Mustafa Akçakoyun; Selçuk Pala; Ali Metin Esen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-03-06       Impact factor: 1.426

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.